A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus
Trial · NCT01644500
Adverse events771
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 771
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | 1.5 mg Dulaglutide | 0 | 244 | 0 |
| other | Anaemia | Blood and lymphatic system disorders | 0.75 mg Dulaglutide | 1 | 248 | 1 |
| other | Anaemia | Blood and lymphatic system disorders | Glimepiride | 1 | 243 | 1 |
| other | Eosinophilia | Blood and lymphatic system disorders | 1.5 mg Dulaglutide | 0 | 244 | 0 |
| other | Eosinophilia | Blood and lymphatic system disorders | 0.75 mg Dulaglutide | 1 | 248 | 1 |
| other | Eosinophilia | Blood and lymphatic system disorders | Glimepiride | 0 | 243 | 0 |
| other | Lymphadenitis | Blood and lymphatic system disorders | 1.5 mg Dulaglutide | 1 | 244 | 1 |
| other | Lymphadenitis | Blood and lymphatic system disorders | 0.75 mg Dulaglutide | 0 | 248 | 0 |
| other | Lymphadenitis | Blood and lymphatic system disorders | Glimepiride | 0 | 243 | 0 |
| other | Atrioventricular block | Cardiac disorders | 1.5 mg Dulaglutide | 0 | 244 | 0 |
| other | Atrioventricular block | Cardiac disorders | 0.75 mg Dulaglutide | 1 | 248 | 1 |
| other | Atrioventricular block | Cardiac disorders | Glimepiride | 0 | 243 | 0 |
| other | Atrioventricular block first degree | Cardiac disorders | 1.5 mg Dulaglutide | 0 | 244 | 0 |
| other | Atrioventricular block first degree | Cardiac disorders | 0.75 mg Dulaglutide | 2 | 248 | 2 |
| other | Atrioventricular block first degree | Cardiac disorders | Glimepiride | 2 | 243 | 2 |
| other | Extrasystoles | Cardiac disorders | 1.5 mg Dulaglutide | 0 | 244 | 0 |
| other | Extrasystoles | Cardiac disorders | 0.75 mg Dulaglutide | 1 | 248 | 2 |
| other | Extrasystoles | Cardiac disorders | Glimepiride | 0 | 243 | 0 |
| other | Left atrial enlargement | Cardiac disorders | 1.5 mg Dulaglutide | 0 | 244 | 0 |
| other | Left atrial enlargement | Cardiac disorders | 0.75 mg Dulaglutide | 0 | 248 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01644500/events